BR0318497A - composto de droga antibacteriana compreendendo n-acetil-d-glucosamina - Google Patents

composto de droga antibacteriana compreendendo n-acetil-d-glucosamina

Info

Publication number
BR0318497A
BR0318497A BRPI0318497-8A BR0318497A BR0318497A BR 0318497 A BR0318497 A BR 0318497A BR 0318497 A BR0318497 A BR 0318497A BR 0318497 A BR0318497 A BR 0318497A
Authority
BR
Brazil
Prior art keywords
glucosamine
acetyl
cgcs
antibiotics
antibacterial drug
Prior art date
Application number
BRPI0318497-8A
Other languages
English (en)
Inventor
Qiwang Xu
Junkang Lin
Zetao Yuan
Original Assignee
Univ Pla 3Rd Military Medical
Bio Wave Inst Suzhou Hi Tec
Beijing Sino Hongkong Dafu Sci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pla 3Rd Military Medical, Bio Wave Inst Suzhou Hi Tec, Beijing Sino Hongkong Dafu Sci filed Critical Univ Pla 3Rd Military Medical
Publication of BR0318497A publication Critical patent/BR0318497A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

"COMPOSTO DE DROGA ANTIBACTERIANA COMPREENDENDO N-ACETIL-D-GLUCOSAMINA". A presente invenção refere-se ao uso da combinação de N-acetil-D-glucosamina e de antibióticos para a preparação de droga antibacteriana. Nas terapias de infecções com antibióticos, os agentes patogênicos podem ser variados para formas mais esguias chamadas células de crescimento críptico (CGCs), as CGCs podem se colonizar e surge a resistência fisiológica à droga. Neste meio-tempo, as colónias normais de bactérias também podem ser mudadas para CGCs pela administração de antibióticos. Estas mudanças resultam em complicações após as terapias, tais como distúrbio de colónias de bactérias no corpo, distúrbio de funções gastrintestinais e outras doenças crónicas. A combinação de antibióticos e N-acetil-D-glucosamina pode prevenir CGC e as complicações após uma terapia com antibióticos.
BRPI0318497-8A 2003-09-18 2003-09-18 composto de droga antibacteriana compreendendo n-acetil-d-glucosamina BR0318497A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2003/000793 WO2005025582A1 (en) 2003-09-18 2003-09-18 Antibacterial compositions of n-acetyl-d-aminoglycosamine and antibiotics

Publications (1)

Publication Number Publication Date
BR0318497A true BR0318497A (pt) 2006-09-12

Family

ID=34280740

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0318497-8A BR0318497A (pt) 2003-09-18 2003-09-18 composto de droga antibacteriana compreendendo n-acetil-d-glucosamina

Country Status (5)

Country Link
US (1) US20070191291A1 (pt)
EP (1) EP1669077A4 (pt)
AU (1) AU2003271022A1 (pt)
BR (1) BR0318497A (pt)
WO (1) WO2005025582A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015067594A1 (en) * 2013-11-05 2015-05-14 Nestec S.A. Use of glucosamine-enriched plant compositions
CN108913768B (zh) * 2018-07-23 2021-10-22 广东省实验动物监测所 一种同时检测七个氨基糖胺类耐药基因的多重液相基因芯片引物、试剂盒及其分析方法
CN111557946A (zh) * 2020-07-01 2020-08-21 上海玉曜生物医药科技有限公司 N-乙酰-d-氨基葡萄糖的新用途及相关产品
WO2025071560A1 (en) * 2023-09-28 2025-04-03 Rutgers, The State University Of New Jersey Methods of diagnosing b cell malignancies, detecting b cell malignancy relapse, and treating thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1318592C (en) * 1988-11-18 1993-06-01 University Of British Columbia N-acetyl glucosamine as a cytoprotective agent
US5217962A (en) * 1992-01-28 1993-06-08 Burton Albert F Method and composition for treating psoriasis
US5455240A (en) * 1994-06-20 1995-10-03 The Rockefeller University Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof
US6426099B1 (en) * 1997-12-03 2002-07-30 Renew Life, Inc. Herbal formulation for rebuilding intestinal bacteria
US6046179A (en) * 1998-04-17 2000-04-04 Murch; Simon Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
US6037333A (en) * 1998-05-07 2000-03-14 Trustees Of Tufts College Microbe-inhibiting compositions
CN1173706C (zh) * 2001-02-28 2004-11-03 中国人民解放军第三军医大学 N-乙酰-d-氨基葡萄糖在制备治疗宫颈糜烂药物中的应用
CN1301112C (zh) * 2002-07-29 2007-02-21 中国人民解放军第三军医大学 含有n-乙酰-d-氨基葡萄糖的复方抗菌药物

Also Published As

Publication number Publication date
EP1669077A4 (en) 2007-10-03
EP1669077A1 (en) 2006-06-14
US20070191291A1 (en) 2007-08-16
AU2003271022A1 (en) 2005-04-06
WO2005025582A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
Wald Risk factors for osteomyelitis
DK0806941T3 (da) Liposomalt antibakterielt præparat med lav fasthed
JP6429131B2 (ja) 膣症を予防および治療するために塩および糖を有効成分として含む皮膚外用組成物およびその使用
WO2007021721A3 (en) Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
BR0110382A (pt) Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
Jang et al. Topical vancomycin for chronic suppurative otitis media with methicillin-resistant Staphylococcus aureus otorrhoea
RU2018107150A (ru) Новый эффективный аминогликозидный антибиотик против бактерий с множественной лекарственной резистентностью
WO2005030109A3 (en) Regimen for the administration of rifamycin-class antibiotics
WO1998024397A3 (en) Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
Thomas et al. Stenotrophomonas maltophilia: a very rare cause of tropical pyomyositis.
Li et al. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial
Ghosen et al. Clinical Study of Rocephinº, a 3rd Generation Cephalosporin, in Various Septicaemias
BR0112035A (pt) peptìdeos antimicrobianos de novispirin
EP1669077A4 (en) ANTIBACTERIAL COMPOSITIONS OF N-ACETYL-D-AMINOGLYCOSAMINE AND ANTIBIOTICS
Neu et al. In vitro activity of fleroxacin in combination with other antimicrobial agents
Chase Toxic effects of streptomycin on the eighth nerve
Altucci et al. Clinical evaluation of tobramycin in respiratory and systemic infections in immunodepressed and normal patients
Brook Clindamycin in treatment of chronic recurrent suppurative otitis media in children
Pulaski et al. Streptomycin in Surgical Infections: III. Otitis Externa, Otitis Media, Mastoiditis, Brain Abscess and Meningitis
Liberti et al. Ciprofloxacin versus chloramphenicol in the treatment of salmonella infection
Fraschini et al. Ceftriaxone therapy in otolaryngological and pulmonary infections
Helium et al. High dose netilmicin therapy of severe or chronic infections
CN101342187A (zh) 一种治疗痢疾的药物组合物
Hughes Antibiotic treatment of chronic bronchitis
Shishido et al. A study on in vitro antibacterial activity and clinical usefulness in respiratory tract infections of panipenem/betamipron, a newly synthesized carbapenem antibiotic

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.